Glenmark Pharmaceuticals : Q4FY 2022-23
"Glenmark Pharmaceuticals Limited Q4 FY'23 Earnings Conference Call" May 22, 2023 MANAGEMENT: MR. GLENN... | May 24, 2023
Source: marketscreener.com
Stay updated with breaking news from Abiraterone Tablets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"Glenmark Pharmaceuticals Limited Q4 FY'23 Earnings Conference Call" May 22, 2023 MANAGEMENT: MR. GLENN... | May 24, 2023
Amneal Pharmaceuticals, Inc announced that it has received approval of an additional strength of 500 mg to its Abbreviated New Drug Application from the FDA for Abiraterone Acetate tablets.